PUMA BIOTECHNOLOGY, INC. Operating Expenses
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Operating Expenses of $70.02 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-08-05
- PUMA BIOTECHNOLOGY, INC. operating expenses for the quarter ending 2021-06-30 was $70.02M, a 10.34% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. operating expenses for the quarter ending 2021-03-31 was $78.02M, a 19.18% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. operating expenses for the quarter ending 2020-12-31 was $63.71M, a 11.01% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. operating expenses for the quarter ending 2020-09-30 was $62.88M, a 11.18% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. operating expenses for fiscal 2020 was $255.51M, a 17.92% decline from fiscal 2019.
- PUMA BIOTECHNOLOGY, INC. operating expenses for fiscal 2019 was $311.31M, a 9.94% decline from fiscal 2018.
- PUMA BIOTECHNOLOGY, INC. operating expenses for fiscal 2018 was $345.65M, a 7.99% increase from fiscal 2017.
- PUMA BIOTECHNOLOGY, INC. operating expenses for fiscal 2017 was $320.07M, a 15.72% increase from fiscal 2016.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 16 month | Operating Expenses 18 month | Operating Expenses 21 month | Operating Expenses 25 month | Operating Expenses 27 month | Operating Expenses 30 month | Operating Expenses 33 month | Operating Expenses 36 month | Operating Expenses 39 month | Operating Expenses 42 month | Operating Expenses 45 month | Operating Expenses 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | $70.02M 10-Q · filed 2021-08-05 | $148.14M 10-Q · filed 2021-08-05 | $211.75M derived: sum of 3 quarters · filed 2021-08-05 | $274.63M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||||||||
| 2021-03-31 | $78.02M 10-Q · filed 2021-05-06 | $141.73M derived: sum of 2 quarters · filed 2021-05-06 | $204.61M derived: sum of 3 quarters · filed 2021-05-06 | $268.07M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||||||||
| 2020-12-31 | $63.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $126.59M derived: sum of 2 quarters · filed 2021-03-01 | $190.04M derived: sum of 3 quarters · filed 2021-08-05 | $255.51M 10-K · filed 2021-03-01 | |||||||||||||||||
| 2020-09-30 | $62.88M 10-Q · filed 2020-11-05 | $126.34M derived: sum of 2 quarters · filed 2021-08-05 | $191.81M 10-Q · filed 2020-11-05 | $263.39M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||||||||
| 2020-06-30 | $63.45M 10-Q · filed 2021-08-05 | $128.92M 10-Q · filed 2021-08-05 | $200.51M derived: sum of 3 quarters · filed 2021-08-05 | $271.31M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||||||||
| 2020-03-31 | $65.47M 10-Q · filed 2021-05-06 | $137.06M derived: sum of 2 quarters · filed 2021-05-06 | $207.85M derived: sum of 3 quarters · filed 2021-05-06 | $287.55M derived: sum of 4 quarters · filed 2021-05-06 | |||||||||||||||||
| 2019-12-31 | $71.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $142.39M derived: sum of 2 quarters · filed 2021-03-01 | $222.09M derived: sum of 3 quarters · filed 2021-03-01 | $311.31M 10-K · filed 2021-03-01 | $311.36M 10-K · filed 2020-02-28 | ||||||||||||||||
| 2019-09-30 | $70.80M 10-Q · filed 2020-11-05 | $150.50M derived: sum of 2 quarters · filed 2020-11-05 | $239.72M 10-Q · filed 2020-11-05 | $329.33M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2019-06-30 | $79.70M 10-Q · filed 2020-08-06 | $168.92M 10-Q · filed 2020-08-06 | $258.53M derived: sum of 3 quarters · filed 2021-03-01 | $332.44M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2019-03-31 | $89.22M 10-Q · filed 2020-05-07 | $178.84M derived: sum of 2 quarters · filed 2021-03-01 | $252.75M derived: sum of 3 quarters · filed 2021-03-01 | $344.96M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2018-12-31 | $89.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $163.53M derived: sum of 2 quarters · filed 2021-03-01 | $255.74M derived: sum of 3 quarters · filed 2021-03-01 | $345.65M 10-K · filed 2021-03-01 | $345.66M 10-K · filed 2019-03-01 | ||||||||||||||||
| 2018-09-30 | $73.91M 10-Q · filed 2019-11-07 | $166.12M derived: sum of 2 quarters · filed 2019-11-07 | $256.03M 10-Q · filed 2019-11-07 | $341.20M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||||||
| 2018-06-30 | $92.21M 10-Q · filed 2019-08-09 | $182.12M 10-Q · filed 2019-08-09 | $267.30M derived: sum of 3 quarters · filed 2020-02-28 | $350.81M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||||||
| 2018-03-31 | $89.91M 10-Q · filed 2019-05-10 | $175.08M derived: sum of 2 quarters · filed 2020-02-28 | $258.60M derived: sum of 3 quarters · filed 2020-02-28 | $336.78M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||||||
| 2017-12-31 | $85.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $168.69M derived: sum of 2 quarters · filed 2020-02-28 | $246.87M derived: sum of 3 quarters · filed 2020-02-28 | $320.07M 10-K · filed 2020-02-28 | |||||||||||||||||
| 2017-09-30 | $83.52M 10-Q · filed 2018-11-05 | $161.70M derived: sum of 2 quarters · filed 2018-11-05 | $234.90M 10-Q · filed 2018-11-05 | $307.77M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||||||
| 2017-06-30 | $78.18M 10-Q · filed 2018-08-09 | $151.38M 10-Q · filed 2018-08-09 | $224.25M derived: sum of 3 quarters · filed 2019-03-01 | $290.25M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||||||
| 2017-03-31 | $73.20M 10-Q · filed 2018-05-10 | $146.07M derived: sum of 2 quarters · filed 2019-03-01 | $212.07M derived: sum of 3 quarters · filed 2019-03-01 | $278.55M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||||||
| 2016-12-31 | $72.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $138.87M derived: sum of 2 quarters · filed 2019-03-01 | $205.35M derived: sum of 3 quarters · filed 2019-03-01 | $276.60M 10-K · filed 2019-03-01 | |||||||||||||||||
| 2016-09-30 | $66.00M 10-Q · filed 2017-11-09 | $132.48M derived: sum of 2 quarters · filed 2017-11-09 | $203.73M 10-Q · filed 2017-11-09 | $265.76M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||||||
| 2016-06-30 | $66.48M 10-Q · filed 2017-08-09 | $137.73M 10-Q · filed 2017-08-09 | $199.76M derived: sum of 3 quarters · filed 2018-03-09 | $260.50M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||||||
| 2016-03-31 | $71.25M 10-Q · filed 2017-05-10 | $133.28M derived: sum of 2 quarters · filed 2018-03-09 | $194.01M derived: sum of 3 quarters · filed 2018-03-09 | $258.93M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||||||
| 2015-12-31 | $62.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $122.77M derived: sum of 2 quarters · filed 2018-03-09 | $187.68M derived: sum of 3 quarters · filed 2018-03-09 | $240.28M 10-K · filed 2018-03-09 | |||||||||||||||||
| 2015-09-30 | $60.73M 10-Q · filed 2016-11-09 | $125.65M derived: sum of 2 quarters · filed 2016-11-09 | $178.25M 10-Q · filed 2016-11-09 | $225.84M derived: sum of 4 quarters · filed 2017-03-01 | |||||||||||||||||
| 2015-06-30 | $64.91M 10-Q · filed 2016-08-09 | $117.51M 10-Q · filed 2016-08-09 | $165.10M derived: sum of 3 quarters · filed 2017-03-01 | $201.06M derived: sum of 4 quarters · filed 2017-03-01 | |||||||||||||||||
| 2015-03-31 | $52.60M 10-Q · filed 2016-05-10 | $100.19M derived: sum of 2 quarters · filed 2017-03-01 | $136.15M derived: sum of 3 quarters · filed 2017-03-01 | $175.06M derived: sum of 4 quarters · filed 2017-03-01 | |||||||||||||||||
| 2014-12-31 | $47.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $83.55M derived: sum of 2 quarters · filed 2017-03-01 | $122.46M derived: sum of 3 quarters · filed 2017-03-01 | $142.28M 10-K · filed 2017-03-01 | |||||||||||||||||
| 2014-09-30 | $35.96M 10-Q · filed 2015-11-09 | $74.86M derived: sum of 2 quarters · filed 2015-11-09 | $94.68M 10-Q · filed 2015-11-09 | $110.67M derived: sum of 4 quarters · filed 2016-02-29 | $234.13M 10-Q · filed 2014-11-10 | ||||||||||||||||
| 2014-06-30 | $38.91M 10-Q · filed 2015-08-10 | $58.72M 10-Q · filed 2015-08-10 | $74.71M derived: sum of 3 quarters · filed 2016-02-29 | $89.04M derived: sum of 4 quarters · filed 2016-02-29 | $198.17M 10-Q · filed 2014-08-11 | ||||||||||||||||
| 2014-03-31 | $19.82M 10-Q · filed 2015-05-11 | $35.81M derived: sum of 2 quarters · filed 2016-02-29 | $50.14M derived: sum of 3 quarters · filed 2016-02-29 | $62.85M derived: sum of 4 quarters · filed 2016-02-29 | $159.27M 10-Q · filed 2014-05-12 | ||||||||||||||||
| 2013-12-31 | $15.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $30.32M derived: sum of 2 quarters · filed 2016-02-29 | $43.03M derived: sum of 3 quarters · filed 2016-02-29 | $54.83M 10-K · filed 2016-02-29 | $139.45M 10-K · filed 2014-03-03 | ||||||||||||||||
| 2013-09-30 | $14.33M 10-Q · filed 2014-11-10 | $27.04M derived: sum of 2 quarters · filed 2014-11-10 | $38.84M 10-Q · filed 2014-11-10 | $60.79M derived: sum of 4 quarters · filed 2015-03-02 | $123.46M 10-Q · filed 2013-11-12 | ||||||||||||||||
| 2013-06-30 | $12.71M 10-Q · filed 2014-08-11 | $24.51M 10-Q · filed 2014-08-11 | $46.46M derived: sum of 3 quarters · filed 2015-03-02 | $72.33M derived: sum of 4 quarters · filed 2015-03-02 | $109.13M 10-Q · filed 2013-08-06 | ||||||||||||||||
| 2013-03-31 | $11.81M 10-Q · filed 2014-05-12 | $33.75M derived: sum of 2 quarters · filed 2015-03-02 | $59.63M derived: sum of 3 quarters · filed 2015-03-02 | $74.40M derived: sum of 4 quarters · filed 2015-03-02 | $96.42M 10-Q · filed 2013-05-09 | ||||||||||||||||
| 2012-12-31 | $21.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $47.82M derived: sum of 2 quarters · filed 2015-03-02 | $62.60M derived: sum of 3 quarters · filed 2015-03-02 | $74.45M 10-K · filed 2015-03-02 | $84.61M 10-K · filed 2013-04-01 | ||||||||||||||||
| 2012-09-30 | $25.87M 10-Q · filed 2013-11-12 | $25.87M 10-Q · filed 2012-11-14 | $40.65M derived: sum of 2 quarters · filed 2013-11-12 | $52.50M 10-Q · filed 2013-11-12 | $52.50M 10-Q · filed 2012-11-14 | $62.29M derived: sum of 4 quarters · filed 2014-03-03 | $62.67M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | $14.78M 10-Q · filed 2013-08-06 | $14.78M 10-Q · filed 2012-08-14 | $26.63M 10-Q · filed 2013-08-06 | $26.63M 10-Q · filed 2012-08-14 | $36.41M derived: sum of 3 quarters · filed 2014-03-03 | $36.75M derived: sum of 4 quarters · filed 2014-03-03 | $36.79M 10-Q · filed 2012-08-14 | ||||||||||||||
| 2012-03-31 | $11.85M 10-Q · filed 2013-05-09 | $11.85M 10-Q · filed 2012-05-15 | $21.64M derived: sum of 2 quarters · filed 2014-03-03 | $21.97M derived: sum of 3 quarters · filed 2014-03-03 | $22.01M derived: sum of 4 quarters · filed 2014-03-03 | $22.02M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $10.12M derived: sum of 2 quarters · filed 2014-03-03 | $10.15M derived: sum of 3 quarters · filed 2014-03-03 | $10.16M 10-K · filed 2014-03-03 | $10.16M 10-K · filed 2012-03-29 | $10.16M 10-K · filed 2012-03-29 | |||||||||||||||
| 2011-09-30 | $333.93K 10-Q · filed 2012-11-14 | $368.20K derived: sum of 2 quarters · filed 2012-11-14 | $372.14K 10-Q · filed 2012-11-14 | $379.07K 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2011-06-30 | $34.27K 10-Q · filed 2012-08-14 | $38.21K 10-Q · filed 2012-08-14 | $45.21K derived: sum of 3 quarters · filed 2013-04-01 | $51.84K derived: sum of 4 quarters · filed 2013-04-01 | |||||||||||||||||
| 2011-03-31 | $3.94K 10-Q · filed 2012-05-15 | $10.94K derived: sum of 2 quarters · filed 2013-04-01 | $17.57K derived: sum of 3 quarters · filed 2013-04-01 | ||||||||||||||||||
| 2010-12-31 | $7.00K 10-K · filed 2013-04-01 | $6.93K 10-K · filed 2012-03-29 | $13.63K derived: sum of 2 quarters · filed 2013-04-01 | ||||||||||||||||||
| 2010-09-30 | $6.63K 10-Q · filed 2011-11-14 | $6.63K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |